Logo image of CLNE

CLEAN ENERGY FUELS CORP (CLNE) Stock Fundamental Analysis

NASDAQ:CLNE - Nasdaq - US1844991018 - Common Stock - Currency: USD

2.4  +0.12 (+5.26%)

After market: 2.3502 -0.05 (-2.07%)

Fundamental Rating

4

Taking everything into account, CLNE scores 4 out of 10 in our fundamental rating. CLNE was compared to 209 industry peers in the Oil, Gas & Consumable Fuels industry. The financial health of CLNE is average, but there are quite some concerns on its profitability. CLNE shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CLNE had positive earnings in the past year.
In the past year CLNE had a positive cash flow from operations.
CLNE had negative earnings in each of the past 5 years.
CLNE had a positive operating cash flow in each of the past 5 years.
CLNE Yearly Net Income VS EBIT VS OCF VS FCFCLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

CLNE has a worse Return On Assets (-18.24%) than 89.95% of its industry peers.
CLNE's Return On Equity of -34.45% is on the low side compared to the rest of the industry. CLNE is outperformed by 82.30% of its industry peers.
Industry RankSector Rank
ROA -18.24%
ROE -34.45%
ROIC N/A
ROA(3y)-6.67%
ROA(5y)-6.22%
ROE(3y)-11.16%
ROE(5y)-9.58%
ROIC(3y)N/A
ROIC(5y)N/A
CLNE Yearly ROA, ROE, ROICCLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

CLNE's Gross Margin of 29.04% is in line compared to the rest of the industry. CLNE outperforms 41.15% of its industry peers.
CLNE's Gross Margin has declined in the last couple of years.
CLNE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.4%
GM growth 5Y-4.26%
CLNE Yearly Profit, Operating, Gross MarginsCLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

5

2. Health

2.1 Basic Checks

CLNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CLNE remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CLNE has more shares outstanding
The debt/assets ratio for CLNE is higher compared to a year ago.
CLNE Yearly Shares OutstandingCLNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CLNE Yearly Total Debt VS Total AssetsCLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.45, we must say that CLNE is in the distress zone and has some risk of bankruptcy.
CLNE has a Altman-Z score of -0.45. This is in the lower half of the industry: CLNE underperforms 71.77% of its industry peers.
The Debt to FCF ratio of CLNE is 10.92, which is on the high side as it means it would take CLNE, 10.92 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 10.92, CLNE is in line with its industry, outperforming 50.72% of the companies in the same industry.
CLNE has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
CLNE has a Debt to Equity ratio of 0.47. This is comparable to the rest of the industry: CLNE outperforms 51.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 10.92
Altman-Z -0.45
ROIC/WACCN/A
WACC9.87%
CLNE Yearly LT Debt VS Equity VS FCFCLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

CLNE has a Current Ratio of 2.83. This indicates that CLNE is financially healthy and has no problem in meeting its short term obligations.
CLNE's Current ratio of 2.83 is amongst the best of the industry. CLNE outperforms 82.78% of its industry peers.
A Quick Ratio of 2.51 indicates that CLNE has no problem at all paying its short term obligations.
CLNE has a Quick ratio of 2.51. This is amongst the best in the industry. CLNE outperforms 82.78% of its industry peers.
Industry RankSector Rank
Current Ratio 2.83
Quick Ratio 2.51
CLNE Yearly Current Assets VS Current LiabilitesCLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

7

3. Growth

3.1 Past

CLNE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 400.00%, which is quite impressive.
Measured over the past years, CLNE shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -21.00% on average per year.
Looking at the last year, CLNE shows a small growth in Revenue. The Revenue has grown by 4.07% in the last year.
The Revenue has been growing slightly by 3.86% on average over the past years.
EPS 1Y (TTM)400%
EPS 3Y58.74%
EPS 5Y-21%
EPS Q2Q%-100%
Revenue 1Y (TTM)4.07%
Revenue growth 3Y17.62%
Revenue growth 5Y3.86%
Sales Q2Q%4.76%

3.2 Future

CLNE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.66% yearly.
CLNE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.81% yearly.
EPS Next Y-564.1%
EPS Next 2Y-102.47%
EPS Next 3Y-45.89%
EPS Next 5Y43.66%
Revenue Next Year2.76%
Revenue Next 2Y6.02%
Revenue Next 3Y6.94%
Revenue Next 5Y21.81%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLNE Yearly Revenue VS EstimatesCLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
CLNE Yearly EPS VS EstimatesCLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 -0.4 -0.6 -0.8 -1

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 48.00, which means the current valuation is very expensive for CLNE.
Based on the Price/Earnings ratio, CLNE is valued a bit more expensive than 66.51% of the companies in the same industry.
CLNE's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.87.
CLNE is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 48
Fwd PE N/A
CLNE Price Earnings VS Forward Price EarningsCLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLNE is valued a bit more expensive than 71.29% of the companies in the same industry.
CLNE's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 20.47
EV/EBITDA 45.9
CLNE Per share dataCLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

A cheap valuation may be justified as CLNE's earnings are expected to decrease with -45.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-102.47%
EPS Next 3Y-45.89%

0

5. Dividend

5.1 Amount

CLNE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLEAN ENERGY FUELS CORP

NASDAQ:CLNE (8/15/2025, 8:12:36 PM)

After market: 2.3502 -0.05 (-2.07%)

2.4

+0.12 (+5.26%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners48.97%
Inst Owner Change-6.42%
Ins Owners1.14%
Ins Owner Change0.58%
Market Cap526.30M
Analysts84
Price Target4.33 (80.42%)
Short Float %5.28%
Short Ratio3.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)103%
Min EPS beat(2)100%
Max EPS beat(2)106%
EPS beat(4)4
Avg EPS beat(4)143.96%
Min EPS beat(4)100%
Max EPS beat(4)185.77%
EPS beat(8)8
Avg EPS beat(8)152.93%
EPS beat(12)11
Avg EPS beat(12)112.95%
EPS beat(16)12
Avg EPS beat(16)74.75%
Revenue beat(2)2
Avg Revenue beat(2)2.05%
Min Revenue beat(2)0.28%
Max Revenue beat(2)3.83%
Revenue beat(4)4
Avg Revenue beat(4)2.69%
Min Revenue beat(4)0.28%
Max Revenue beat(4)4.45%
Revenue beat(8)5
Avg Revenue beat(8)-1.01%
Revenue beat(12)7
Avg Revenue beat(12)0.27%
Revenue beat(16)8
Avg Revenue beat(16)-1.03%
PT rev (1m)0%
PT rev (3m)-33.91%
EPS NQ rev (1m)2.71%
EPS NQ rev (3m)13.58%
EPS NY rev (1m)0%
EPS NY rev (3m)56.05%
Revenue NQ rev (1m)1.27%
Revenue NQ rev (3m)-1.97%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.21%
Valuation
Industry RankSector Rank
PE 48
Fwd PE N/A
P/S 1.25
P/FCF 20.47
P/OCF 5.13
P/B 0.89
P/tB 0.9
EV/EBITDA 45.9
EPS(TTM)0.05
EY2.08%
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.12
FCFY4.88%
OCF(TTM)0.47
OCFY19.49%
SpS1.92
BVpS2.69
TBVpS2.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.24%
ROE -34.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.04%
FCFM 6.11%
ROA(3y)-6.67%
ROA(5y)-6.22%
ROE(3y)-11.16%
ROE(5y)-9.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.4%
GM growth 5Y-4.26%
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 10.92
Debt/EBITDA 28.05
Cap/Depr 81.3%
Cap/Sales 18.27%
Interest Coverage N/A
Cash Conversion 1028.62%
Profit Quality N/A
Current Ratio 2.83
Quick Ratio 2.51
Altman-Z -0.45
F-Score5
WACC9.87%
ROIC/WACCN/A
Cap/Depr(3y)180.71%
Cap/Depr(5y)126.79%
Cap/Sales(3y)20.16%
Cap/Sales(5y)15.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)400%
EPS 3Y58.74%
EPS 5Y-21%
EPS Q2Q%-100%
EPS Next Y-564.1%
EPS Next 2Y-102.47%
EPS Next 3Y-45.89%
EPS Next 5Y43.66%
Revenue 1Y (TTM)4.07%
Revenue growth 3Y17.62%
Revenue growth 5Y3.86%
Sales Q2Q%4.76%
Revenue Next Year2.76%
Revenue Next 2Y6.02%
Revenue Next 3Y6.94%
Revenue Next 5Y21.81%
EBIT growth 1Y-97.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year236.53%
EBIT Next 3Y64.03%
EBIT Next 5Y48.15%
FCF growth 1Y141.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y272.51%
OCF growth 3Y16.07%
OCF growth 5Y39.37%